To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
KHI Announces New Members of the KHI Board of Directors
KHI thanks the Nominating Committee for preparing the 2016 Call for Nominations and slate. The KHI Board of Directors welcomes new members David Baron, PhD, and Marcus Ketteler, MD, to the Board starting in January 2017.
Additionally, a special thanks to members who completed their term in 2016 – Patrick Archdeacon, MD, Dolph Chianchano, JD, MPA, and Alan Kliger, MD. In particular, we would like to acknowledge Founding Co-Chair, Patrick Archdeacon, MD, for his leadership and guidance, which were instrumental in establishing KHI.
For a more detailed update on KHI Board of Directors, please click here.
Open Call for Workgroups
The following is a list of current opportunities for KHI members to volunteer their service on a project workgroup. Click on the title for more information and details on how to volunteer.
Involvement in workgroups is on a voluntary basis with no compensation provided. All workgroup members are required to submit an online disclosure form with their application.
KHI Attends the White House Organ Summit
KHI is pleased to support President Barack Obama's call to action through its attendance at the White House Organ Summit on Monday, June 13. This Summit will examine ways to improve the outcomes for individuals waiting for organ transplants and support living donors in addition to improving kidney patient care options and transplantation access.
KHI has submitted the following commitment statement in support of the White House Initiative
The Kidney Health Initiative, a public-private partnership established by the U.S. Food and Drug Administration and the American Society of Nephrology and composed of more than 75 member organizations, will initiate the development of a roadmap that will describe scientific, technical, and regulatory milestones needed to achieve the goal of creating a bioartificial or bioengineered alternative to dialysis as renal replacement therapy. The roadmap will also consider challenges, provide "state of the art" expectations for entrepreneurs and other technology developers, and spur innovation in producing functioning kidney replacements by engaging stakeholders, identifying research priorities to alleviate critical knowledge gaps, and advancing the science of alternatives to dialysis.
The roadmap was presented as a project proposal at the Fourth Annual KHI Stakeholders Meeting in May 2016. The proposal can be viewed on the KHI Meetings Page.
KHI Announces New Members of the Patient and Family Partnership Council (PFPC)
The KHI Patient and Family Partnership Council (PFPC) was established in May 2015. KHI is pleased to welcome three new members to the PFPC, fulfilling the organizational structure as a 10 member Council.
Pamela Duquette, is the mother of a child with FSGS and represents NephCure International.
Nichole Jefferson has experienced both peritoneal and hemo-dialysis treatments. Nichole received a kidney transplant in the summer of 2008.
David White has experienced in-center hemo-dialysis, in-center nocturnal hemo-dialysis, and peritoneal dialysis. Dave received a kidney transplant in the summer of 2015.
To learn more about the PFPC or its members, please visit the PFPC page.
Fourth Annual KHI Stakeholders Meeting
The Fourth Annual KHI Stakeholders Meeting took place at the DoubleTree by Hilton Hotel Washington DC- Silver Spring in Silver Spring, MD on May 25-26, 2016. The Stakeholders Meeting brought together our diverse membership from the kidney community to connect members across different fields, share ideas, collect feedback, and collaborate on new and proposed projects.
Please visit the KHI Meetings Page for more information on the Fourth Annual KHI Stakeholders Meeting.
KHI Annual Report 2014-2015
On behalf of the Board of Directors, we would like to thank the KHI membership for their participation in KHI, which has seen its membership grow from 47 organizations in September 2013, to more than 75 organizations in December 2015. The membership has worked diligently through KHI to improve patient safety and promote the development of optimal therapies for diseases that affect kidneys and the quality of life for millions of people.
View KHI's 2014-2015 Annual Report.
View the KHI Inaugural Review 2012-2014.
If you have any questions about KHI, or would like more information about becoming a member, please contact email@example.com.